| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/05/2004 | CN1493290A Ferulaic acid piperazine drip pill and its preparation method |
| 05/05/2004 | CN1493289A Hydroxy camptothecin emulsion and its preparation method |
| 05/05/2004 | CN1493288A Hanfangchin A drip pill and its preparation method |
| 05/05/2004 | CN1493287A Shishan alkaloid drip pill and its preparation method |
| 05/05/2004 | CN1493286A Drip pill medicine composition for treating diabetes and its complication and productive method thereof |
| 05/05/2004 | CN1493285A Composite blood pressure reducing preparation containing indapamide and calcium ion rivalry agent |
| 05/05/2004 | CN1493284A Composite blood pressure reducing agent containing indapamide and angiotensin II acceptor antagonist |
| 05/05/2004 | CN1493283A Edalavon powder for ampoul injection having good stability and its preparation method |
| 05/05/2004 | CN1493282A Composite blood pressure reducing preparation containing indapamide and bela retarder or beta and alpha retarder |
| 05/05/2004 | CN1493281A Coumarin acetate drip pill and its preparation method |
| 05/05/2004 | CN1493280A Mezereum drip pill and its preparation method |
| 05/05/2004 | CN1493279A Norcantharidin drip pill and its preparation method |
| 05/05/2004 | CN1493278A Silymarin behenic acid glyceride lipid nano particle oral solution dosage and its preparation method |
| 05/05/2004 | CN1493277A Rare earth hetero poly acid salt kind antigrip virus medicine and its synthesis method |
| 05/05/2004 | CN1493276A Ferulaic acid sodium drip pill and its preparation method |
| 05/05/2004 | CN1493275A Paeonol drip pill and its preparation method |
| 05/05/2004 | CN1493274A Vanillic aldehyde drip pill and its preparation method |
| 05/05/2004 | CN1493270A Composition of component of skin whitening cosmetics |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148378C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 05/05/2004 | CN1148372C Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action |
| 05/05/2004 | CN1148369C 1,8-naphthyridine derivatives |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
| 05/05/2004 | CN1148357C Triazole derivative |
| 05/05/2004 | CN1148356C Benzosulfone derivatives |
| 05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
| 05/05/2004 | CN1148352C 6.7-disubstituted-5,8-quinolinedione derivatives as antifungal agent |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/05/2004 | CN1148349C N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor |
| 05/05/2004 | CN1148347C Method for making hydroxy-25-ene-vitamin D compounds |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/05/2004 | CN1148227C Therapeutic compound and its application |
| 05/05/2004 | CN1148226C Aqueous risperidone formulations |
| 05/05/2004 | CN1148221C Chinese-medicinal antihypertensive pillow |
| 05/05/2004 | CN1148205C Medicine for treating perineum disease |
| 05/05/2004 | CN1148203C Medicine for treating onychomycosis |
| 05/05/2004 | CN1148199C Chinese medicated food containing gensenoside and its production process |
| 05/05/2004 | CN1148194C New use of polyunsaturated lecithin |
| 05/05/2004 | CN1148193C Application of oligose treating stress brani injury |
| 05/05/2004 | CN1148192C Cell-protecting amifostine and its preparing process |
| 05/05/2004 | CN1148191C Contraceptive compositions and preparation process thereof |
| 05/05/2004 | CN1148190C Immunodulatory drug composition |
| 05/05/2004 | CN1148189C Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
| 05/05/2004 | CN1148188C Analgesics |
| 05/05/2004 | CN1148187C Application of tetrandrine its agonist for preparing medicine for treatment of ocular inflammation |
| 05/05/2004 | CN1148186C Clonidine preparation |
| 05/05/2004 | CN1148185C Inhibitor for generation of 3-deoxyglucurone |
| 05/05/2004 | CN1148184C Composite medicine for optical dynamic treatment of tumor |
| 05/05/2004 | CN1148183C Indoly-3-glyoxylic acid derivatives with antitumoral activity |
| 05/05/2004 | CN1148182C Application of tea polyphenol in preparing medicine to suppress beta-amyloid aggregation and fibroplasia |
| 05/05/2004 | CN1148181C Use of flavnolignanes for the prepn. of medicaments with antiproliferative activity in uterus, ovary and breast |
| 05/05/2004 | CN1148180C Compounds for treatment of estrogen-dependent illnesses and methods for making and using same |
| 05/05/2004 | CN1148179C 20-Hete antagonists and agonists |
| 05/05/2004 | CN1148178C Mixtures separated from seeds of syzygium, preparations thereof, and uses as medicines containing them and components therefrom |
| 05/05/2004 | CN1148177C Pharmaceutical compositions comprising flurbiprofen |
| 05/05/2004 | CN1148176C Compsn. contg. cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases |
| 05/05/2004 | CN1148175C Use of calcium L-threonate in prevention and inhibition of osteoporosis and rickets |
| 05/05/2004 | CN1148174C Nimesulide gel system for topical use |
| 05/05/2004 | CN1148173C Liniment for preventing pig bite |
| 05/05/2004 | CN1148172C Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 05/05/2004 | CN1148169C Process for manufacture of (sub) micron sized particles by dissolving in compressed gas and surfactants |
| 05/05/2004 | CN1148168C Micronised pharmaceutical compositions |
| 05/04/2004 | US6730809 Processes for the production of α-difluoromethyl ornithine (DFMO) |
| 05/04/2004 | US6730794 Substituted indolealkanoic acids |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730787 Viricides, immunostimulants, antitubercular, anticarcinogenic, antitumor, antidepressant, antichlamydial, and analgesic agents; psychological disorders |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730781 Using ceramic hydroxyapatite column chromatography; avoids toxic organic solvents and animal enzymes, centrifugations, tedious precipitation |
| 05/04/2004 | US6730707 Method for reducing intraocular pressure using indole derivatives |
| 05/04/2004 | US6730706 Treatments using venlafaxine |
| 05/04/2004 | US6730704 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines, process for preparation thereof and use thereof as hypoglycemic agents |
| 05/04/2004 | US6730703 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 05/04/2004 | US6730702 Sulfodehydroabietic acid monosodium salt pentachloride; prophylactic or therapeutic effect thereof on intestinal mucosal injury |
| 05/04/2004 | US6730701 6-methoxy-2-naphthylacetic acid derivative as a prodrugs, useful for treatment of inflammation in humans |
| 05/04/2004 | US6730699 Water soluble paclitaxel derivatives |
| 05/04/2004 | US6730698 Method and compositions for administering taxanes orally to human patients |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730693 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 05/04/2004 | US6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 05/04/2004 | US6730691 Ophthalmic solution for inhibiting visual anomalies experienced by an individual who undergone refractive eye surgery comprising alpha adrenergic blocking agents, one or more anti-irritant agents, and one or more anti-inflammatory |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730689 Heterocyclic amides such as n-(4-(2-(((methyl)amino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders |
| 05/04/2004 | US6730686 Methods for inhibiting oxidative modification of proteins |
| 05/04/2004 | US6730685 H+,k+-atpase inhibitor in a water free solvent; ready-to-use solution for parenteral administration |
| 05/04/2004 | US6730683 Such as 1-cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors |
| 05/04/2004 | US6730682 Herpes virus |
| 05/04/2004 | US6730681 Anxiolytic agents and anticonvulsants |
| 05/04/2004 | US6730679 Possessing unexpectedly enhanced bio-availability |
| 05/04/2004 | US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior. |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730675 Such as 7-chloro-4-hydroxy-2-(2,5-dimethyl(3-furanyl)) methyl-1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-dione which binds nmda receptors (n-methyl-aspartic acid receptors); neuropathy |
| 05/04/2004 | US6730674 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 05/04/2004 | US6730673 Pharmaceutical solutions of levosimendan |
| 05/04/2004 | US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 05/04/2004 | US6730670 7-phenyl-benzo[b]thiophen amide derivatives |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/04/2004 | US6730666 Inhibition of growth factor tyrosine kinase receptor activity, particularly inhibition of angiogenesis and related disorders, tumor progression and growth factor related skeletal disorders, by porphyrin and corrole compounds |
| 05/04/2004 | US6730665 2-methoxy estradiol (2me) is cytotoxic to osteosarcoma cells |